Navarre already has 12 cases of monkeypox

Navarre already has 12 cases of monkeypox


Spain registered 365 more cases of coronavirus this Friday monkey pox (“Monkeypox”) and remains the European country and the second largest in the world hardest hit by this outbreak, which has already infected a total of 4,942 people, of whom 139 have been hospitalized and two have died. Navarre, which has initiated selective and phased vaccination against monkey pox, has already reported 12 cases.

These are the data that the Ministry of Health has just updated and that claim Spain as the first European country – it brings together almost half of the 11,536 positives recorded on the continent – and second worldwide – surpassed only by the United States. which exceeds the 7,100 people most affected by this alert, declared an international health emergency in late July.

According to Health, 365 new infections have been reported since Tuesday; Of the 4,436 cases for which this information is available, 2.8% (139) required hospitalization.

MADRID, IN MY HEAD

Meanwhile, the deceased remain with two young men, one from the Valencian community, another 31-year-old boy from Cordoba.

Nine deaths have been confirmed worldwide, in addition to the two in Spain, three in Nigeria, two in the Central African Republic, one in Ghana and one in India, although the WHO is investigating other deaths that may be linked to this outbreak.

By commune, Madrid continues to be the country with the highest number of cases, with 1,817, ahead of Catalonia (1,558) and, much further afield, Andalusia (661), the Valencian Community (284); Basque Country (130); Canary Islands (118) and Balearic Islands (111).

It is followed by Galicia (71); Aragon (47) and Asturias (47); Castile and León (41); Castile-La Mancha (36); Murcia (26); Extremadura (21); Cantabria (18); Navarre (12) and La Rioja, with 4.

CHARACTERISTICS OF THE CASES

The vast majority of patients reported to the surveillance system in Spain (Sivies), 4,863, are men and 79 are women. Age ranges from 10 months to 88 years, with the median remaining at 37. The last one started with symptoms the last 2 Tuesdays.

Of those with clinical information, six out of ten had it anogenital rash (59.4%) and just over half (55.1%), Fever. They also introduced themselves rash in other places (51.8% neither anogenital nor oral-buccal) and lymphadenopathy (50.7%).

These symptoms were followed by asthenia (32.8%); muscle pain (25.2%); headache (23.5%); oro-buccal rash (19.9%) and sore throat (13.3%).

According to the report, 237 cases had complications with other symptoms throughout their clinical course, with the most common being mouth ulcers and secondary bacterial infections.

Eight out of ten infected people (3,943, 79.78%) are men who have sex with men (MSM). The most likely mechanism of transmission in 2,287 cases for which this information is available was by close contact related to sexual intercourse in 80.6% of the cases and close non-sexual contact in 9.1% of the cases.

There is also data on participation in major events in 3,152 cases; 646 of them took part in one in the days before the onset of symptoms.

WAITING FOR 7,000 MORE VACCINES

Meanwhile, Spain is still awaiting the arrival of 7,000 vaccines, more than the 11,400 it purchased through Hera, the European Authority for Preparedness and Response to Health Emergencies, in addition to another 200 purchased from a third country.

The Health Secretary indicated last Tuesday that that would be the case by the end of this week or early next week, although she clarified yesterday that that would be the case “in the coming weeks”. They will join the 5,000 that communities have already started playing on-demand with.

The simian virus vaccination schedule provides for pre-exposure prophylaxis in those with high-risk practices and post-exposure from close contacts of confirmed cases, particularly in those at high risk of serious illnesses such as children, pregnant women, and immunocompromised individuals.

Also for healthcare and laboratory workers with contact with positives who have impacted the use of their protective equipment (PPE).

.



Source link

Leave a Comment

Your email address will not be published.

Exit mobile version